Nutex Health Inc.

NASDAQ: NUTX · Real-Time Price · USD
92.91
-18.22 (-16.40%)
At close: Aug 15, 2025, 3:59 PM
94.04
1.22%
After-hours: Aug 15, 2025, 07:49 PM EDT

Nutex Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
624.28M 479.95M 292M 275.93M 258.77M 247.65M 231.7M 197.37M 196.5M 146.38M 157.68M 247.26M 252.02M 247.83M 288.93M 171.52M 109.35M
Cost of Revenue
319.84M 283.69M 224.15M 222.93M 218.69M 212.87M 209.61M 208.82M 212.59M 165.61M 177.17M 164.27M 144.89M 141.98M 77.7M 36.16M 3.01M
Gross Profit
304.44M 196.26M 67.85M 53M 40.08M 34.77M 22.09M -11.44M -16.1M -19.23M -19.49M 82.99M 107.13M 105.84M 211.24M 135.37M 106.34M
Operating Income
201.38M 130.62M 20.49M 10.05M 4.39M -1.51M -11.36M -449.6M -445.33M -457.25M -433.04M 80.43M 104.13M 116.35M 161.25M 86.16M 56.87M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a 368.00 368.00 638.00 883.00 629.00 1.66K 1.39K 1.14K
Pretax Income
172.67M 109.75M -29.54M -31.82M -40.81M -48.49M -26.63M -463.55M -462.3M -471.04M -447.57M 69.16M 103.14M 115.24M 161.2M 88.01M 58.08M
Net Income
96.77M 52.18M -41.13M -37.89M -41M -45.79M -24.83M -452.53M -472.52M -483.95M -458.23M 28.8M 79.34M 91.46M 116.66M 64.62M 37.79M
Selling & General & Admin
59.88M 58.56M 40.26M 36.28M 35.7M 36.07M 33.24M 29.47M 21.95M 30.67M -78.98M -81.51M -82.46M -95.82M 48.6M 47.75M 47.61M
Research & Development
n/a n/a n/a n/a n/a n/a -73.75K -73.75K -73.75K n/a 282.91K 355.18K 414.81K 417.77K 262.91K 264.47K 519.1K
Other Expenses
7.08M 7.08M 7.1M 6.72M 53.21K 270.47K 344.22K 291.02K 291.02K 290.2K -1.65M 92.73K 4.15M 4M 4.86M 3.11M -949.03K
Operating Expenses
66.97M 65.64M 47.36M 42.95M 35.7M 36.28M 33.46M 29.69M 22.16M 30.96M -84.56M -87.09M -88.04M -101.55M 50.46M 49.68M 49.85M
Interest Expense
21.61M 19.93M 19.12M 17.83M 17.62M 16.32M 14.94M 14.25M 13.77M 12.49M 11.57M 9.43M 6.57M 5.04M 4.84M 3.56M 1.81M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a 11.05K 11.05K 11.05K 11.05K 9.74K 9.74K 4.49K 57.16K
Cost & Expenses
386.81M 349.33M 271.51M 265.88M 254.38M 249.16M 243.07M 238.51M 234.76M 196.56M 180.1M 164.67M 144.34M 127.93M 127.69M 85.37M 52.39M
Income Tax Expense
32.63M 14.48M 2.87M -2.06M -3.77M -5.07M -263.35K -8.46M 12M 12.91M 10.66M 19.66M 486.05K 455.36K 895.54K 441.92K -39.58K
Shares Outstanding (Basic)
5.1M 5.1M 5.1M 4.97M 4.5M 4.02M 3.69M 3.56M 4.05M 4.53M 4.33M 4.29M 3.95M 4.66M 3.98M 3.95M 3.95M
Shares Outstanding (Diluted)
5.1M 5.1M 5.1M 4.97M 4.6M 4.22M 4.43M 4.38M 4.65M 4.92M 4.33M 4.31M 3.95M 3.95M 3.95M 3.95M 3.95M
EPS (Basic)
10.24K 10.23K -1.73K -9.51 -10.42 -11.61 -6.1 -104.64 -109.14 -112.06 -106.48 7.06 19.39 22.46 27.73 14.57 7.77
EPS (Diluted)
10.24K 10.23K -1.73K -8.9 -9.62 -10.65 -5.32 -104.11 -108.77 -111.85 -105.87 7.78 20.08 23.15 27.84 14.57 7.77
EBITDA
214.15M 148.65M 7.95M 4.16M -5.52M -14.7M 4.42M -422.89M -423.44M -438.41M -437.77M -14.49M -18.31M -6.72M 59.35M 61.18M 62.31M
EBIT
125.39M 129.68M -10.42M -13.99M -23.19M -32.17M -11.69M -438.97M -438.71M -404.78M -401.05M 26.76M 54.34M 20.95M 86.55M 88.56M 61.43M
Depreciation & Amortization
19.88M 18.97M 18.37M 18.15M 17.79M 17.6M 16.23M 15.82M 14.88M 11.11M 8.02M 3.88M 845.21K 692.29K 1.17M 1.03M 881.32K